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In this report, we discuss key issues for the successful
application of MALDI-TOF mass spectrometry to quantify
drugs. These include choice and preparation of matrix,
nature of cationization agent, automation, and data analy-
sis procedures. The high molecular weight matrix meso-
tetrakis(pentafluorophenyl)porphyrin eliminates chemical
noise in the low-mass range, a “brushing” spotting
technique in combination with prestructured target plates
enables fast preparation of homogeneous matrix crystals,
and addition of Li+ leads to intense cationized drug
species. Complex biological samples were cleaned up
using a 96-well solid-phase extraction plate, and the
purified samples were automatically spotted by a pipetting
robot. To obtain a suitable data analysis procedure for the
quantitative analysis of drugs by MALDI-TOF mass spec-
trometry, various data processing parameters were evalu-
ated on our two model drugs lopinavir and ritonavir.
Finally, and most importantly, it is shown that the above-
described procedure can be successfully applied to quan-
tify clinically relevant concentrations of lopinavir, an HIV
protease inhibitor, in extracts of small numbers of pe-
ripheral blood mononuclear cells (1  106).
In our pediatrics departments, we need a fast, reliable, and
sensitive method to quantify antiretroviral drugs in various
biological samples, such as extracts from peripheral blood mono-
nuclear cells (PBMCs). To this end, we have initiated a study to
test the suitability of matrix-assisted laser desorption/ionization
time-of-flight (MALDI-TOF) mass spectrometry for such clinical
applications.
MALDI and electrospray ionization (ESI) are the two most
extensively used ionization techniques for the mass spectrometric
analysis of biological and biomedical compounds. However, only
ESI is commonly used for qualitative and quantitative analysis of
low molecular weight compounds (<1000 Da) such as drugs. This
is because, in contrast to MALDI, ESI does not require the
addition of matrix molecules; such matrix molecules may undergo
association reactions leading to interference peaks in the low-mass
range. Nevertheless, MALDI offers some specific advantages over
ESI. Perhaps the most important distinction of MALDI is that it
is capable of very high sample throughput with minimum
instrument maintenance. In addition, MALDI is less susceptible
to ion suppression. It is for these reasons that in recent years
MALDI has seen its emergence in the field of small-molecule
analysis.1
Two major phenomena hamper the application of the MALDI
technique to the analysis of small molecules. As mentioned above,
MALDI suffers from matrix-derived chemical interference in the
low-mass range.2 From a quantitative perspective, MALDI suffers
from poor reproducibility of the signal abundance.1
The molecular masses of conventional MALDI matrixes range
from 100 to 300 Da. Due to ion/molecule reactions in the matrix
plume, a large number of matrix-derived peaks are usually
observed in the low-mass range.2 For example, the often used
matrix 2,5-dihydroxybenzoic acid (DHB; C7H6O4) produces, after
laser irradiation, the series of (C7H5O4Na)nNa+ ions in admixture
with other adducts, even in the presence of residual sodium ions.3
These abundant matrix-related peaks seriously hamper the
qualitative and quantitative analysis of small molecules. One way
to avoid such interference signals is to choose a matrix whose
molecular weight is in excess of that of the analyte molecule.4,5
Meso-tetrakis(pentafluorophenyl)porphyrin (F20TPP) is such a
high molecular MALDI matrix (MW ) 974.6 Da) and has
successfully been used for the analysis of various small molecules,
for example, poly(ethylene glycol)s, fatty acids, and sugars.6-8
A variety of approaches have been reported to enhance the
signal reproducibility of MALDI mass spectrometers, and they
can be divided into two main groups: (1) enhancement of
homogeneous matrix crystallization. enhancement of homoge-
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neous analyte incorporation into the matrix crystals, or both. This
can be achieved, for example, by preparing matrix crystals using
a fast evaporation protocol or by using prestructured target
plates.9,10 (2) averaging out variations in instrument response by
employing an internal standard and by averaging out multiple
spectra of one sample.11-13
In this study, a strategy is presented to overcome the two main
limitations of MALDI-TOF mass spectrometry for the qualitative
and quantitative analysis of small molecules. To reduce the
number of matrix-derived peaks in the low-mass range, we have
used a high molecular weight matrix, viz. F20TPP. To increase
reproducibility (precision), we have developed, using prestruc-
tured target plates, a fast evaporation protocol for the matrix
F20TPP. To increase reproducibility further, instrument response
variation was minimized by using an internal standard, by
averaging out 1000 spectra per sample, and by measuring each
sample 4-fold. In addition, the effects of various data analysis
procedures on the precision and accuracy of analyte abundances
was investigated. Finally, we demonstrate that MALDI-TOF mass
spectrometry can be successfully used for the quantitative analysis
of lopinavir, an HIV protease inhibitor, in extracts of PBMCs.
EXPERIMENTAL SECTION
Pharmaceutical Compounds. Lopinavir and ritonavir were
kindly provided by Abbott Laboratories. Indinavir was kindly
supplied by Merck Sharp & Dohme. Saquinavir was kindly
provided by F. Hoffmann-La Roche. Nelfinavir was kindly provided
by Pfizer Inc. Zidovudine, lamivudine, abacavir, and amprenavir
were kindly provided by GlaxoSmithKline. Nevirapine and tipranavir
were kindly provided by Boehringer Ingelheim. Erythromycin,
omeprazole, carbamazepine, sulfamethoxazole, levofloxacin, pri-
maquine, metoprolol, acetylsalicylic acid, amikacin, tobramycin,
ampicillin, acetaminophen, trimethoprim, penicillin G, and rifampi-
cin were purchased from Sigma-Aldrich.
Chemicals. Lithium iodide, sodium iodide, potassium iodide,
rubidium iodide, cesium iodide, HPLC grade water, and 5,10,15,-
20-tetrakis(pentafluorophenyl)porphyrin were obtained from Sigma-
Aldrich. All organic solvents were obtained from J. T. Baker. All
chemicals were purchased at the highest purity grade available
and were used without further purification.
Standards for Qualitative Analysis. Dilution series for each
pharmaceutical compound were prepared in ethanol/water (1:1).
Dilution series A contained pharmaceutical compounds at a
concentration of 8000, 4000, 2000, 1000, and 500 fmol/íL. Dilution
series B contained pharmaceutical compounds at a concentration
of 80, 40, 20, 10, and 5 fmol/íL. Samples were stored at -20 °C.
Standards for Quantitative Analysis of Pure Lopinavir and
Ritonavir. Calibrators were prepared of pure lopinavir and
ritonavir at concentrations of 1000, 900, 800, 700, 500, 400, 300,
200, 100, 80, 40, 20, 15, 10, 5, and 1 fmol/íL. Each calibrator was
spiked with 50 fmol/íL indinavir (internal standard). All calibra-
tors were prepared in ethanol/water (1:1) and stored at - 80 °C.
Standards for Quantitative Analysis of Lopinavir in PBMC
Extracts. PBMCs were isolated from a buffy coat (Sanquin) using
a Ficoll density gradient. Calibrators were prepared of pure
lopinavir in ethanol/water (1:1) at concentrations of 4000, 3000,
2000, 1000, 400, 200, 100, 50, and 25 fmol/íL spiked with 500
fmol/íL saquinavir (internal standard). A 100-íL aliquot of each
calibrator was added to a dry pellet of 1  106 PBMCs, and PBMCs
were extracted overnight in these calibrator solutions at 5 °C.
Subsequently, cell debris was spun down and supernatants were
loaded onto a 96-well solid-phase extraction plate (Oasis HLB
íelution plate, Waters). The loaded samples were washed twice
with 200 íL of methanol/water (1:19) and 200 íL of methanol/
water (1:1), respectively. Samples were eluted from the solid-phase
extraction plate using 100 íL of methanol/water (3:1). The eluted
samples were dried using a SpeedVac (Savant) and were stored
at -20 °C. On the day of analysis, the dried samples were
reconstituted in 100 íL of ethanol/water (1:1).
Matrix and Matrix Spotting Technique. Four parts of 25
mg/mL F20TPP, dissolved in 100% acetone, were mixed with one
part of 100 mM LiI, NaI, KI, RbI, or CsI. LiI, and NaI, dissolved
in 100% acetone, and KI, RbI, and CsI were dissolved in 100%
methanol. Thus, the final matrix solutions contained 20 mg/mL
F20TPP and 20 mM alkali iodide. Matrix crystals were prepared
on an AnchorChip target plate with 800-ím sized hydrophilic
anchors (Bruker Daltonics) by the following “brushing” tech-
nique: A 10-íL pipet tip was filled with matrix solution. Next, the
pipet was positioned such that the tip just touched the target plate
above the first spot. Next, the plunger was slightly pressed and
at the same time the pipet was quickly dragged downward over
the target spots.
Sample Spotting. All samples were spotted in 4-fold (1 íL/
replicate) on top of the matrix crystals using a ClinProtRobot
pipetting robot, which was controlled by ClinProtRobot Workflow,
Editor version 1.0 software (Bruker Daltonics, Germany).
Sample Measurement. All experiments were performed on
an Ultraflex MALDI-TOF/TOF mass spectrometer (Bruker Dal-
tonics) equipped with a 50-Hz nitrogen laser (337 nm). Mass
spectra were recorded in the positive ion reflectron mode.
FlexControl version 2.4 software was used to operate the mass
spectrometer. A sample spot containing matrix only was used to
manually set the laser power 5% above the threshold for
ionization. The samples containing the analytes were measured
automatically using the AutoXecute part of the FlexControl
software. Mass spectra were recorded by accumulating 50 shots
on 20 different positions on each sample spot. No spectra were
rejected (i.e., fuzzy control for spectra accumulation was not used).
Four replicates of each sample were measured, and each experi-
ment was repeated three times.
Data Analysis. A FlexAnalysis script, kindly provided by
Bruker Daltonics, was used to process the raw mass spectra in
batch and to pick all peaks for a specified m/z range. Each mass
spectrum was processed with and without baseline subtraction,
and peak picking was performed using the “centroid” peak picking
algorithm (monoisotope only) as well as the “SNAP” peak picking
algorithm (all isotopes). Baseline subtraction was performed using
the “median” baseline subtraction algorithm with 0.8 flatness. For
the centroid peak picking algorithm, the signal-to-noise ratio (S/
N) threshold was set at 3 times above the standard deviation of
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(10) Vorm, O.; Roepstorff, P.; Mann, M. Anal. Chem. 1994, 66, 3281-3287.
(11) Duncan, M. W.; Matanovic, G.; Cerpa-Poljak, A. Rapid Commun. Mass
Spectrom. 1993, 7, 1090-1094.
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the noise. The S/N threshold was set at 5 for the SNAP peak
picking algorithm. Subsequently, a “search for masses” macro,
kindly provided by Bruker Daltonics, was used to automatically
extract in batch peak parameters (peak intensity, peak S/N, and
peak area) for specific masses (analyte and internal standard) from
the peak lists generated by the above-described FlexAnalysis
script.
Precision and Accuracy Calculations. Full analysis was
performed when the analyte and internal standard were present
at S/N > 3 or > 5 (vide supra) in at least two out of the four
replicates. Of each experiment, the consecutive series of concen-
tration calibrators that fulfilled the FDA ( 20/15 criteria for
precision14 was used for accuracy calculations, using the mean
analyte-to-internal standard response ratios of the replicates of
each calibrator. The consecutive series of calibrators was chosen
in such way that it contained the calibrator with the lowest analyte
(14) FDA 2001 available at http://www.fda.gov/cder/guidance/4252fnl.pdf.
Figure 1. Analysis of lopinavir using F20TPP as matrix. a.i., absolute intensity. The molecular weight of lopinavir (LPV) is 628.8 Da. Panel A:
An intense signal for lithiated lopinavir was observed when 1 pmol of lopinavir was analyzed with 20 mg/mL F20TPP + 20 mM LiI. No protonated
lopinavir was observed. Panel B: A signal was observed for lopinavir cationized by residual sodium ions when 1 pmol of lopinavir was analyzed
with 20 mg/mL F20TPP. No protonated lopinavir was observed.
Figure 2. Abundances of free cations from equimolar alkali iodide salts. a.i., absolute intensity. Panel A: mass spectrum of 20 mg/mL F20TPP
+ 4 mM LiI, NaI, KI, RbI, and CsI. No free lithium ions were observed. Panel B: mass spectrum of 10 mg/mL DHB + 4 mM LiI, NaI, KI, RbI,
and CsI. No free lithium ions were observed.
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concentration. Unweighed, 1/x weighed, and 1/x2 weighed linear,
and quadratic curve fitting methods were applied to construct the
calibration curves. Calibrators with the highest analyte concentra-
tion of a consecutive series were removed one by one until that
calibrator series fulfilled the FDA ( 20/15 criteria for accuracy.14
Outliers were not removed unless otherwise stated.
RESULTS AND DISCUSSION
Meso-Tetrakis(pentafluorophenyl)porphyrin Matrix. The
use of MALDI mass spectrometry for the quantitative analysis of
drugs is normally hampered by interfering matrix peaks in the
low-mass range and poor precision of signal abundances.1 Meso-
tetrakis(pentafluorophenyl)porphyrin (F20TPP) has a high mo-
lecular weight (MW 974.6 Da) compared to other more commonly
used matrixes such as DHB (MW 154.1 Da) and R-cyano-4-
hydroxycinnamic acid (MW 189.2 Da). Ayorinde et al. have shown
that only a few interfering matrix peaks are observed in the low-
mass range of F20TPP, which is prerequisite for the analysis of
small molecules.7 To perform high-throughput quantitative analy-
sis of drugs, we have developed a protocol for the rapid prepara-
tion of homogeneous F20TPP matrix crystals using prestructured
target plates. F20TPP was dissolved in acetone and spotted on a
hydrophobic target plate with hydrophilic anchors (AnchorChip)
using a simple brushing. Each anchor absorbed 0.2 íL of matrix
solution, and homogeneous matrix crystals formed within 1 s. The
matrix can be spotted on all 384 anchors of a single target plate
within 5 min. Samples were spotted on top of the matrix crystals,
and since F20TPP is not soluble in water, ethanol, or methanol,
the sample solvent simply evaporates without perturbing matrix
crystal homogeneity. Considering the good precision we can
achieve (vide infra), we conclude that the analyte is indeed
homogeneously incorporated into the matrix.
Upon laser irradiation, F20TPP forms radical cations and it also
undergoes self-protonation. These protonated molecules may serve
as proton donors for the analyte molecules. Our model compounds
lopinavir and ritonavir contain peptide bonds, which have high
proton affinities (PA).15 Thus, we expected that lopinavir and
ritonavir would become protonated within the MALDI plume.
However, no signals were observed for the protonated analytes
when F20TPP was used as matrix (see Figure 1). Thus, F20TPP
does not transfer a proton to the analyte, presumably because
the PA of F20TPP is higher than that of lopinavir and ritonavir.
Another way to ionize molecules by MALDI is to add an alkali
salt leading to alkali ion attachment. Indeed, for molecules lacking
basic sites, such as sugars, cationization can be accomplished by
the addition of alkali ions.3 This is also true when using the matrix
F20TPP, which is usually mixed with sodium or potassium salts
to ionize the analytes of interest.6-8,16 We investigated the effect
of lithium, sodium, potassium, rubidium, and cesium iodide on
the detection limits of lopinavir and ritonavir. Iodide was chosen
as counteranion, because the lower lattice energy of alkali iodides
compared to other alkali halides results in more free gaseous alkali
ions and, thus, higher signal abundances of the cationized
analytes.17 Considering the above argument based on lattice
energies, it might reasonably be expected that for the alkali iodides
the concentration of gaseous alkali ions will be in the order Li+
< Na+ < K+ < Rb+ < Cs+. This is indeed observed. In Figure 2
are shown the MALDI-TOF mass spectra of equimolar amounts
of the alkali iodides using F20TPP (Figure 2A) and DHB (Figure
2B) as matrix. As can be seen, the amount of gas-phase ions
available for cationization is highest for Cs+, whereas virtually no
lithium ions are liberated. On the other hand, the alkali affinity of
(15) Lias, S. G.; Bartmess, J. E.; Liebman, J. F.; Holmes, J. L.; Levin, R. O.;
Maillard, W. G. J. Phys. Chem. Ref. Data 1988.
(16) Ayorinde, F. O.; Garvin, K.; Saeed, K. Rapid Commun. Mass Spectrom. 2000,
14, 608-615.
(17) Hoberg, A. M.; Haddleton, D. M.; Derrick, P. J.; Jackon, A. T.; Scrivens, J.
H. Eur. Mass Spectrom. 1998, 4, 435-440.
Figure 3. Distribution of cationized PEG600 using equimolar alkali iodide salts. a.i., absolute intensity. Panel A: mass spectrum of PEG600
analyzed with 20 mg/mL F20TPP + 4 mM LiI, NaI, KI, RbI, and CsI. The most abundant signals were observed for lithiated PEG600, followed
by sodiated PEG600. PEG600 did not form adducts with potassium, rubidium, or cesium. Panel B: mass spectrum of PEG600 analyzed with
10 mg/mL DHB + 4 mM LiI, NaI, KI, RbI, and CsI. The abundance of cationized PEG600 signals was as follows: K > Na > Li > Rb  Cs. The
solid line represents the cation distribution for PEG600 with a chain length of 13 CH2CH2O units.
5406 Analytical Chemistry, Vol. 78, No. 15, August 1, 2006
substrates will be in the opposite order, viz. Li+ > Na+ > K+ >
Rb+ > Cs+, because the smaller the ionic radius, the more stable
the association of the alkali ion with the substrate will be (ion-
dipole stabilization energies are inversely proportional to the
square of the distance between the charge and substrate binding
location). Thus, there are two opposing effects, to wit bare alkali
ion availability and substrate alkali ion affinity. That there indeed
are two opposing effects is borne out by cationization experiments
using poly(ethylene glycol)s (PEGs) cationized by equimolar
amounts of alkali iodides using DHB as matrix (see Figure 3B).
An optimum for alkali attachment to the PEG chain was obtained
for potassium in agreement with the operation of the two opposing
effects discussed above. However, cationization experiments with
PEGs and F20TPP showed a completely different distribution of
the cationized PEG (see Figure 3A): An optimum alkali attach-
ment to the PEG chain was obtained for lithium. Our two model
compounds lopinavir and ritonavir showed a similar cation
distribution when analyzed with F20TPP (Figure 4). The highest
signal abundances for cationized lopinavir and ritonavir were
observed when F20TPP was mixed with lithium iodide. We
therefore conclude that alkali cationization using the F20TPP
matrix does not occur by attachment of free lithium ions in the
gas phase. This is in sharp contrast to results obtained with low
molecular weight matrixes, such as DHB, where free cation
attachment is the predominant process.18 The mechanism of alkali
attachment to pharmaceutical compounds using the matrix
F20TPP is currently under investigation in our laboratories. For
now, we will exploit the observation that lithium attachment
produces the most intense signals. The combination of F20TPP
and lithium iodide was therefore used as matrix for all other
experiments.
Qualitative Analysis of Pharmaceutical Compounds. We
obtained the detection limits (S/N g 3) for the lithiated monoiso-
topic peaks of 26 drugs using the F20TPP matrix. Most of the
drugs tested in this experiment are used to treat HIV or other
infectious diseases. In addition, we tested drugs that are frequently
prescribed or used to treat neurological diseases. The best
detection limits were obtained for the HIV protease inhibitors
lopinavir, ritonavir, saquinavir, indinavir, and nelfinavir (5 fmol).
The HIV protease inhibitors amprenavir and tipranavir were
detected up to 10 and 40 fmol, respectively. Erythromycin (10
fmol), omeprazole (10 fmol), carbamazepine (40 fmol), sul-
famethoxazole (40 fmol), and levofloxacin (40 fmol) were detected
at levels comparable to that of the HIV protease inhibitors. The
detection limits for the HIV reverse transcriptase inhibitors
lamivudine, nevirapine, zidovudine, and abacavir ranged from 500
to 1000 fmol. Comparable detection limits were obtained for
primaquine (500 fmol), metoprolol (500 fmol), acetylsalicylic acid
(18) Zhang, J.; Zenobi, R. J. Mass Spectrom. 2004, 39, 808-816.
Figure 4. Effects of equimolar alkali iodide salts on the signal abundances of lopinavir and ritonavir (n ) 12).
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(500 fmol), amikacin (1000 fmol), and tobramycin (1000 fmol).
Ampicillin could be detected up to 4000 fmol, and acetaminophen,
trimethoprim, penicillin G, and rifampicin could not be detected
using the F20TPP matrix.
Quantitative Analysis of Pure Lopinavir and Ritonavir. In
the life sciences, MALDI-TOF mass spectrometry is mostly used
for qualitative analysis of compounds such as peptides and
proteins. As a consequence, little is known as to how data should
be treated for quantitative analysis of small molecules. Therefore,
we tested the effect of baseline subtraction, choice of peak
parameter (intensity, S/N, area), and choice of analyte signal
(monoisotope, all isotopes) on the precision of the lopinavir and
ritonavir abundances. The results are shown in Table 1. For each
entry, 16 concentrations of lopinavir and ritonavir were measured
in 4-fold using indinavir as internal standard, and the average
precision was calculated together with the standard deviation. The
above procedure was performed three times, and from these three
experiments, the average precision and standard deviation was
extracted. Thus, the entries in Table 1 are the result of 192
measurements. The peak parameter “area” resulted in slightly
better precisions of the lopinavir and ritonavir abundance com-
pared to the peak parameter “intensity” or “S/N”. Baseline
subtraction did not have an effect on the precision. It can be seen
that for lopinavir the precision deteriorates significantly when all
isotopes are used. By contrast, for ritonavir no significant changes
were observed. The poor precision of lopinavir when signal
abundances of all isotopes were used may well be due to
contamination of other compounds leading to interferences under
the isotopic peaks of lopinavir.
Subsequently, we investigated whether drugs could be quanti-
fied by MALDI-TOF mass spectrometry according to the (20/
15 criteria of the FDA for precision and accuracy: Precision
(expressed as relative standard deviation) and accuracy (ex-
pressed as % deviation from the theoretical concentration) should
be e15% for all calibrators except for the lower limit of quantifica-
tion (LLOQ), which should be e20%.14 Table 2 shows the effects
of baseline subtraction, choice of peak parameter (intensity, S/N,
area), and choice of analyte signal (monoisotope, all isotopes) on
the dynamic range of the lopinavir and ritonavir calibration curves
that fulfilled the FDA ( 20/15 criteria for precision and accuracy.
In general the best, i.e., largest, dynamic ranges were obtained
by applying no baseline subtraction and by using the monoisotopic
peak area. The application of baseline subtraction when the
monoisotopic peak abundance of lopinavir was used resulted in a
marked decrease in dynamic range. This effect was attributed to
the increase in LLOQ from 1 (no baseline subtraction) to 5 fmol
(baseline subtraction). This effect was not observed for ritonavir.
In general, the LLOQ increased when the signal abundances of
all isotopes were used compared to the use of the monoisotopic
peak abundance.
Table 3 shows the effects of the six curve fitting methods on
the mean dynamic range of lopinavir and ritonavir. Quadratic curve
fitting resulted in a larger dynamic range compared to linear curve
fitting. Furthermore, the effect of weighing on the dynamic range,
ordered from best to worst, was 1/x2 weighing > 1/x weighing >
unweighed curve fitting. The FDA states that the simplest model
that accurately describes the concentration-response relationship
Table 1. Effects of Twelve Data Analysis Procedures
on the Mean Precisions (% CV) of All Calibrators of
Lopinavir and Ritonavira
procedures LPV RTV
monoisotope no intensity 11 10
monoisotope yes intensity 12 10
monoisotope no S/N 11 10
monoisotope yes S/N 12 10
monoisotope no area 8 9
monoisotope yes area 9 9
all isotopes no intensity 19 9
all isotopes yes intensity 15 9
all isotopes no S/N 19 9
all isotopes yes S/N 18 9
all isotopes no area 13 9
all isotopes yes area 11 9
a LPV, lopinavir. RTV, ritonavir. The left column shows which analyte
signal was used (monoisotope, all isotopes), whether a baseline
subtraction was used or not (yes/no), and which peak parameter was
used (intensity, S/N, area).
Table 2. Effects of Twelve Data Analysis Procedures
on the Mean Dynamic Range of Lopinavir and
Ritonavira
procedures RTV LPV
monoisotope no intensity 33 86
monoisotope yes intensity 53 24
monoisotope no S/N 56 78
monoisotope yes S/N 53 21
monoisotope no area 74 186
monoisotope yes area 74 35
all isotopes no intensity 33 21
all isotopes yes intensity 32 19
all isotopes no S/N 50 19
all isotopes yes S/N 53 21
all isotopes no area 53 35
all isotopes yes area 50 10
a RTV, ritonavir. LPV, lopinavir. The left column shows which analyte
signal was used (monoisotope, all isotopes), whether a baseline
subtraction was used or not (yes/no), and which peak parameter was
used (intensity, S/N, area). Calibrator series of lopinavir and ritonavir
were analyzed in 4-fold, and experiments were repeated three times.
Subsequently, data were analyzed using 12 data analysis procedures
(left column of the table), and precisions were calculated for the
lopinavir and ritonavir calibrators. Calibrators that fulfilled the FDA (
20/15 criteria for precision were used to construct calibration curves
in the following way: six curve fitting methods were applied and
calibrators with the highest analyte concentration were removed one
by one until the calibration curve fulfilled the FDA ( 20/15 criteria
for accuracy. Reported here is the mean of the all dynamic ranges
obtained by applying various curve fitting methods for each of the 12
data analysis procedures.
Table 3. Effects of Six Curve Fitting Methods on the
Mean Dynamic Range Lopinavir and Ritonavira
linear quadratic
compound unweighed
1/x
weighed
1/x2
weighed unweighed
1/x
weighed
1/x2
weighed
ritonavir 25 50 54 41 69 69
lopinavir 16 41 54 30 59 76
a Linear unweighed, linear 1/x weighed, linear 1/x2 weighed,
quadratic unweighed, quadratic 1/x weighed, and quadratic 1/x2
weighed curve fitting methods were used to construct lopinavir and
ritonavir calibration curves. Here we report the mean dynamic range
of all 12 data analysis procedures (see Table 2) for each curve fitting
method.
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should be used to construct a calibration curve.19 In addition, the
selection of weighing and use of complex regression equation
should be justified,19 which we do here. MALDI-TOF mass
spectrometers are typically equipped with 8-bit analog-to-digital
converters (ADC). These ADCs convert the intensity of the
detector output into a numerical value of 0-255.20 Therefore, the
dynamic range of MALDI-TOF mass spectrometers is generally
limited to 2 orders of magnitude. Indeed, for our MALDI-TOF
mass spectrometer, the concentration-response relationship was
approximately linear when relative low concentrations of lopinavir
were analyzed (up to 100 fmol), while the concentration-response
relationship was more quadratic for higher lopinavir concentra-
tions (see Figure 5). Furthermore, weighing functions were
applied to reduce the influence of the higher concentrations on
the fitted line, since the variance of the instrument response
increases with the analyte concentration.19 In conclusion, the best
dynamic ranges were obtained using the following data analysis
procedure: No baseline subtraction, the use of the monoisotopic
peak area, and construction of a calibration curve using a 1/x2
weighed quadratic curve fitting method. Table 4 shows the
precisions and accuracies of lopinavir and ritonavir when using
this data analysis procedure.
Quantitative Analysis of Lopinavir in Cell Extracts. Next,
we investigated whether MALDI-TOF mass spectrometry could
be used to quantify clinically relevant concentrations of lopinavir
in PBMC extracts according to the FDA ( 20/15 criteria for
precision and accuracy. Crommentuyn et al. reported a mean
intracellular lopinavir concentration in 11 HIV-1 infected adults
of 6.4 pmol/1  106 PBMCs just before drug intake, and the peak
concentration was 8.5 pmol/1  106 PBMCs.21 The results of our
experiments are shown in Table 5. As can be seen, our procedure
allows the quantification of lopinavir down to 25 fmol in extracts
of 1  106 PBMCs according to the FDA ( 20/15 criteria for
precision and accuracy. This is well below the clinically relevant
concentrations mentioned above. These results clearly show that
MALDI-TOF mass spectrometry can be successfully used for
clinical studies on the intracellular pharmacology of lopinavir. In
Figure 6 are shown the mass spectra of PBMC extracts. It can be
seen that after solid-phase extraction the spectra are remarkably
clean. Considering that the mean signal-to-noise ratio (n ) 12)
obtained at the LLOQ was 9 (sd 2.3), better quantification limits
seem possible.
In clinical studies on the intracellular pharmacology of anti-
retroviral drugs, aqueous mixtures containing a high percentage
of organic solvent are used to extract the antiretroviral drugs from
the PBMCs. We therefore prepared calibrator series of lopinavir
in ethanol/water (1:1), and these calibrators were used to extract
1  106 PBMCs. One million PBMCs were used for these
experiments, since this amount of PBMCs can be obtained from
a blood sample of 1-2 mL, a prerequisite for clinical studies in
HIV-1 infected children.
A time-of-flight mass analyzer is normally not the first choice
for quantitative analysis of drugs. As described above, the dynamic
range is relatively small due to the use of analog-to-digital
(19) Garofolo, F. In Analytical method validation and intstrument performance
verification.; Chan, C. C., Lam, H., Lee, Y. C., Zhang, X. M., Eds.; John Wiley
& Sons: New York, 2004; pp 105-138.
(20) In Mass spectrometry: A textbook; Gross, J. H., Ed.; Springer: New York,
2004; pp 113-130.
(21) Crommentuyn, K. M.; Mulder, J. W.; Mairuhu, A. T.; van Gorp, E. C.;
Meenhorst, P. L.; Huitema, A. D.; Beijnen, J. H. Antiviral Ther. 2004, 9,
779-785.
Figure 5. Concentration-response relationship of lopinavir using
MALDI-TOF mass spectrometry. LPV, lopinavir; IDV, indinavir. Verti-
cal bars represent plus and minus one standard deviation.
Table 4. Quantitative Analysis of Pure Lopinavir and
Ritonavira
lopinavir ritonavir
exp 1 exp 2 exp 3 exp 1 exp 2 exp 3
LLOQ (fmol) 1 1 1 5 5 15
ULOQ (fmol) 200 300 500 900 500 700
mean precision 6.3 ( 2.0 6.8 ( 3.6 6.1 ( 3.9 7.0 ( 3.7 7.7 ( 3.1 7.3 ( 4.6
mean accuracy 5.9 ( 4.2 6.7 ( 4.3 5.1 ( 3.1 4.9 ( 3.4 5.1 ( 3.5 3.7 ( 3.0
a LLOQ, lower limit of quantification. ULOQ, upper limit of quan-
tification. exp, experiment. Calibrator series of pure lopinavir and
ritonavir were measured in 4-fold, and experiments were repeated three
times. Precisions of the mean analyte-to-internal standard response
ratios for each calibrator were calculated using the monoisotopic peak
areas. Calibrators that fulfilled the FDA ( 20/15 criteria for precision
were used to construct calibration curves in the following way: A 1/x2
quadratic curve fitting method was applied, and calibrators with the
highest analyte concentration were removed one by one until the
calibration curve fulfilled the FDA ( 20/15 criteria for accuracy. The
reported precisions and accuracies are the mean values for all
calibrators that fulfilled the (20/15 criteria for precision and accuracy.
Table 5. Quantitative Analysis of Lopinavir in PBMC
Extractsa
exp 1 exp 2 exp 3
LLOQ (fmol) 25 25 25
ULOQ (fmol) 4000 3000 2000
mean precision 7.4 ( 3.7 8.4 ( 4.8 6.2 ( 3.4
mean accuracy 5.5 ( 5.3 5.7 ( 4.6 4.9 ( 4.4
a LLOQ, lower limit of quantification. ULOQ, upper limit of quan-
tification. exp, experiment. Processed calibrator series were measured
in 4-fold, and experiments were repeated three times. The mean
analyte-to-internal standard responses were calculated for each calibra-
tor using the monoisotopic peak areas. Calibration curves were
constructed using a 1/x2 weighed quadratic curve fitting. The reported
precisions and accuracies are the mean values for all calibrators that
fulfilled the FDA ( 20/15 criteria for precision and accuracy. In
experiment 3, one outlier was removed.
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converters with an 8-bit size. Furthermore, most time-of-flight
analyzers are not designed to perform tandem mass experiments
(MS/MS) on small molecules in contrast to, for example, triple
quadrupole mass analyzers. Tandem mass experiments are used
to increase signal-to-noise ratios and selectivity of drug measure-
ments. Therefore, the development of new types of MALDI mass
spectrometers, such as MALDI-triple quadrupole mass spectrom-
eters, is of special interest for the quantitative analysis of
drugs.12,22-24
Sample volumes typically used in MALDI mass spectrometry
are in the order of 1 íL. The challenge for the successful
application of MALDI mass spectrometry for quantitative analysis
of drugs is to concentrate analytes in such a small volume in a
reproducible manner. In our experiment, we reconstituted the
processed calibrators in 100 íL of ethanol/water, but only 1 íL
was spotted on to the target plate. Thus, a factor 100 in sensitivity
was lost. Nevertheless, the obtained quantification limit of at least
25 fmol for lopinavir in cell extracts allows reliable and clinical
applications of our procedure. However, loss in sensitivity of a
factor 100 could complicate the quantitative analysis of other drugs
that have lower intracellular concentrations than lopinavir. To
circumvent this problem, smaller solvent volumes could be used
to reconstitute calibrators after vacuum-drying. Another way is
to elute calibrators in a smaller volume from the solid-phase
extraction plate and to directly spot the eluents onto the target
plate. For example, Gobey et al. eluted calibrators in volumes of
25 íL and spotted the eluents directly onto a target plate prior to
quantitative analysis using a MALDI-triple quadrupole mass
spectrometer.22
One of the hallmarks of MALDI mass spectrometry is the
speed of analysis. On our MALDI-TOF mass spectrometer, a
typical time to analyze a sample in 4-fold in an automated way
was 2 min and 20 s. Our MALDI-TOF mass spectrometer is
equipped with a 50-Hz nitrogen laser, and the use of higher
repetition rate lasers could further decrease analysis time to a
few seconds as described by Volmer and co-workers.12 Fast sample
preparation techniques are needed to exploit the high-throughput
capacity of MALDI mass spectrometers. To this end, we have used
96-well solid-phase extraction plates allowing fast sample prepara-
tion. In addition, our pipetting robot is compatible with the 96-
well format, allowing fast, automated, and reproducible sample
spotting. Furthermore, using the described brushing, the matrix
can be spotted onto the target plate in 5 min.
CONCLUSIONS
We have constructed a protocol by which pharmaceutical
drugs, especially HIV protease inhibitors, can be successfully
quantified in peripheral blood mononuclear cells using MALDI-
TOF mass spectrometry. We have examined various acquisition
procedures and postacquisition processing parameters. Crucial
for acquiring reliable data is the use of a high molecular weight
matrix, thereby virtually eliminating chemical noise, and the use
of Li+ to achieve efficient cationization of the drug. The choice of
postacquisition data analysis procedures has a profound effect on
the quantitative performance of the MALDI-TOF mass spectrom-
etry technique. The best results were obtained using the monoiso-
topic peak areas of the analyte and internal standard, weighed
quadratic curve fitting to construct the calibration curves, and no
baseline subtraction. Using our protocol, we were able to quantify
clinically relevant concentrations of lopinavir in cell extracts
according to the (20/15 criteria of the FDA for precision and
accuracy.
(22) Gobey, J.; Cole, M.; Janiszewski, J.; Covey, T.; Chau, T.; Kovarik, P.; Corr,
J. Anal. Chem. 2005, 77, 5643-5654.
(23) Sleno, L.; Volmer, D. A. Rapid Commun. Mass Spectrom. 2005, 19, 1928-
1936.
(24) Sleno, L.; Volmer, D. A. Anal. Chem. 2005, 77, 1509-1517.
Figure 6. Mass spectra of PBMC extracts analyzed by MALDI-TOF mass spectrometry. a.i., absolute intensity. Panel A: mass spectrum of
1  106 PBMCs that were extracted using ethanol/water without adding drugs. Panel B: mass spectrum of 1  106 PBMCs that were extracted
using ethanol/water spiked with internal standard only (500 fmol/íL saquinavir). Panel C: mass spectrum of 1  106 PBMCs that were extracted
using ethanol/water spiked with internal standard (500 fmol/íL saquinavir) and analyte (2000 fmol/íL lopinavir).
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